Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hallucinations | 7 | 2021 | 360 | 2.070 |
Why?
|
| Psychotic Disorders | 11 | 2022 | 2826 | 2.020 |
Why?
|
| Schizophrenia | 18 | 2021 | 6741 | 1.400 |
Why?
|
| Delusions | 2 | 2013 | 299 | 0.770 |
Why?
|
| Schizophrenic Psychology | 5 | 2017 | 1683 | 0.620 |
Why?
|
| Bipolar Disorder | 9 | 2020 | 5050 | 0.540 |
Why?
|
| Auditory Cortex | 2 | 2021 | 328 | 0.520 |
Why?
|
| Mental Health Services | 2 | 2020 | 1608 | 0.440 |
Why?
|
| Psychomotor Performance | 2 | 2019 | 1944 | 0.400 |
Why?
|
| Fructose | 1 | 2010 | 296 | 0.330 |
Why?
|
| Cerebellum | 3 | 2021 | 1491 | 0.320 |
Why?
|
| Public Health | 1 | 2020 | 2374 | 0.320 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2021 | 34394 | 0.260 |
Why?
|
| Ambulatory Care | 1 | 2015 | 2773 | 0.250 |
Why?
|
| Mental Disorders | 2 | 2022 | 6423 | 0.250 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 1001 | 0.230 |
Why?
|
| Brain Mapping | 5 | 2021 | 6548 | 0.220 |
Why?
|
| Somatosensory Disorders | 1 | 2022 | 48 | 0.220 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3158 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3276 | 0.210 |
Why?
|
| Pandemics | 2 | 2021 | 7213 | 0.210 |
Why?
|
| Temporal Lobe | 2 | 2021 | 1659 | 0.200 |
Why?
|
| Auditory Pathways | 1 | 2021 | 229 | 0.180 |
Why?
|
| Memory | 3 | 2015 | 2149 | 0.180 |
Why?
|
| Frontal Lobe | 2 | 2016 | 1426 | 0.180 |
Why?
|
| Substance-Related Disorders | 2 | 2015 | 4189 | 0.170 |
Why?
|
| Rest | 2 | 2015 | 878 | 0.170 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2019 | 194 | 0.160 |
Why?
|
| Amphetamine-Related Disorders | 2 | 2010 | 64 | 0.160 |
Why?
|
| Brain | 7 | 2021 | 25188 | 0.140 |
Why?
|
| Social Work | 1 | 2015 | 148 | 0.130 |
Why?
|
| Adult | 20 | 2021 | 212129 | 0.130 |
Why?
|
| Neural Pathways | 3 | 2015 | 3023 | 0.130 |
Why?
|
| Azabicyclo Compounds | 1 | 2013 | 68 | 0.120 |
Why?
|
| Child Abuse | 1 | 2022 | 984 | 0.120 |
Why?
|
| Humans | 30 | 2022 | 715124 | 0.120 |
Why?
|
| Patient Dropouts | 1 | 2015 | 426 | 0.120 |
Why?
|
| Social Adjustment | 1 | 2015 | 638 | 0.120 |
Why?
|
| Prefrontal Cortex | 2 | 2015 | 2059 | 0.110 |
Why?
|
| NAD | 1 | 2016 | 613 | 0.110 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 13268 | 0.110 |
Why?
|
| Functional Laterality | 2 | 2017 | 2299 | 0.110 |
Why?
|
| Nerve Fibers, Unmyelinated | 1 | 2012 | 105 | 0.110 |
Why?
|
| Sleep Stages | 2 | 2013 | 695 | 0.100 |
Why?
|
| Suicide, Attempted | 1 | 2019 | 1154 | 0.100 |
Why?
|
| Nerve Net | 2 | 2021 | 2146 | 0.100 |
Why?
|
| Psychotherapy | 1 | 2019 | 1564 | 0.090 |
Why?
|
| Face | 1 | 2016 | 983 | 0.090 |
Why?
|
| Female | 18 | 2021 | 377334 | 0.090 |
Why?
|
| Young Adult | 8 | 2021 | 56155 | 0.090 |
Why?
|
| Myelin Sheath | 1 | 2013 | 649 | 0.090 |
Why?
|
| Neuropsychological Tests | 3 | 2019 | 6922 | 0.090 |
Why?
|
| Polysomnography | 2 | 2013 | 1747 | 0.090 |
Why?
|
| Male | 18 | 2021 | 351081 | 0.090 |
Why?
|
| Models, Neurological | 2 | 2022 | 1778 | 0.080 |
Why?
|
| Adolescent | 6 | 2022 | 84999 | 0.080 |
Why?
|
| Piperazines | 2 | 2013 | 2540 | 0.080 |
Why?
|
| Alcohol-Related Disorders | 1 | 2010 | 238 | 0.080 |
Why?
|
| Sleep | 2 | 2013 | 4210 | 0.080 |
Why?
|
| Pain | 1 | 2022 | 4662 | 0.080 |
Why?
|
| Cocaine-Related Disorders | 1 | 2010 | 453 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2016 | 3705 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 23283 | 0.070 |
Why?
|
| Hypnotics and Sedatives | 1 | 2013 | 1118 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2016 | 3163 | 0.070 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2011 | 1989 | 0.070 |
Why?
|
| Axons | 1 | 2013 | 1736 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 19499 | 0.060 |
Why?
|
| Tobacco Use Disorder | 1 | 2010 | 696 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 16011 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2015 | 2592 | 0.060 |
Why?
|
| Tomography, Emission-Computed | 2 | 2004 | 1148 | 0.060 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2013 | 2188 | 0.060 |
Why?
|
| Methamphetamine | 1 | 2004 | 134 | 0.060 |
Why?
|
| Massachusetts | 1 | 2015 | 8734 | 0.060 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 4849 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2013 | 6198 | 0.060 |
Why?
|
| Hippocampus | 1 | 2015 | 3654 | 0.050 |
Why?
|
| Pindolol | 1 | 2001 | 31 | 0.050 |
Why?
|
| Comorbidity | 1 | 2015 | 10423 | 0.050 |
Why?
|
| Raphe Nuclei | 1 | 2001 | 102 | 0.050 |
Why?
|
| Receptors, Serotonin | 1 | 2001 | 208 | 0.050 |
Why?
|
| Psychopathology | 1 | 2022 | 371 | 0.050 |
Why?
|
| Prognosis | 1 | 2020 | 29168 | 0.050 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2004 | 619 | 0.040 |
Why?
|
| Cerebral Cortex | 2 | 2012 | 5718 | 0.040 |
Why?
|
| Conditioning, Classical | 1 | 2021 | 378 | 0.040 |
Why?
|
| Catatonia | 1 | 2019 | 147 | 0.040 |
Why?
|
| Middle Aged | 5 | 2013 | 214871 | 0.040 |
Why?
|
| Opioid-Related Disorders | 1 | 2010 | 1863 | 0.040 |
Why?
|
| Employment | 1 | 2021 | 1100 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 810 | 0.030 |
Why?
|
| Mood Disorders | 1 | 2001 | 1106 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 39285 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 70704 | 0.030 |
Why?
|
| Serotonin Uptake Inhibitors | 1 | 2001 | 1428 | 0.030 |
Why?
|
| Fear | 1 | 2021 | 1378 | 0.030 |
Why?
|
| Social Perception | 1 | 2016 | 419 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2020 | 72255 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 2334 | 0.020 |
Why?
|
| Visual Perception | 1 | 2019 | 1408 | 0.020 |
Why?
|
| Anxiety | 1 | 2004 | 3898 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2004 | 6293 | 0.020 |
Why?
|
| Pyridines | 1 | 2001 | 2867 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2010 | 462 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 2313 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2016 | 6531 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2021 | 7836 | 0.020 |
Why?
|
| Depression | 1 | 2004 | 7256 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2012 | 21790 | 0.020 |
Why?
|
| Child | 2 | 2022 | 74146 | 0.010 |
Why?
|
| Prevalence | 1 | 2019 | 14869 | 0.010 |
Why?
|
| Receptors, Serotonin, 5-HT1 | 1 | 2001 | 14 | 0.010 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2001 | 177 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 162674 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2010 | 8998 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2013 | 11900 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2022 | 41181 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2013 | 5829 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 2011 | 3067 | 0.010 |
Why?
|
| Arousal | 1 | 2004 | 1142 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 5061 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2004 | 1997 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 2001 | 1205 | 0.010 |
Why?
|
| Attention | 1 | 2004 | 2415 | 0.010 |
Why?
|
| Kinetics | 1 | 2001 | 6802 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2004 | 2978 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2004 | 2973 | 0.010 |
Why?
|
| Animals | 1 | 2021 | 170726 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 2001 | 2836 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 39804 | 0.010 |
Why?
|
Concepts
(131)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(41)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_